Revolution Medicines: On Hold Pending A Lower Entry Point (NASDAQ:RVMD)

Scientists working in the laboratory


Shares of oncology concern Revolution Medicines, Inc. (NASDAQ:RVMD) have more than doubled since the market initially reacted negatively to a clinical update on lead asset RMC-6236 in October 2023. The company’s novel approach to treating cancer with

Source link

Previous post Even the Raspberry Pi is getting in on AI
Next post CrowdStrike Holdings, Inc. (CRWD) CEO George Kurtz presents at BofA Securities 2024 Global Technology Conference (Transcript)